Journal of Molecular Endocrinology (2009) 43 251-261 DOI: 10.1677/JME-09-0053
© 2009 Society for Endocrinology
Thioredoxin and thioredoxin reductase influence estrogen receptor
-mediated gene expression in human breast cancer cells
Abhi K Rao1,
Yvonne S Ziegler2,
Ian X McLeod3,
John R Yates3 and
Ann M Nardulli2
Departments of
1 Cellular and Developmental Biology
2 Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, Illinois 61801, USA
3 Department of Cell Biology, The Scripps Institute, LaJolla, California 92037, USA
(Correspondence should be addressed to A M Nardulli; Email: anardull{at}life.uiuc.edu)
Accumulation of reactive oxygen species (ROS) in cells damages resident proteins, lipids, and DNA. In order to overcome the oxidative stress that occurs with ROS accumulation, cells must balance free radical production with an increase in the level of antioxidant enzymes that convert free radicals to less harmful species. We identified two antioxidant enzymes, thioredoxin (Trx) and Trx reductase (TrxR), in a complex associated with the DNA-bound estrogen receptor
(ER
). Western analysis and immunocytochemistry were used to demonstrate that Trx and TrxR are expressed in the cytoplasm and in the nuclei of MCF-7 human breast cancer cells. More importantly, endogenously expressed ER
, Trx, and TrxR interact and ER
and TrxR associate with the native, estrogen-responsive pS2 and progesterone receptor genes in MCF-7 cells. RNA interference assays demonstrated that Trx and TrxR differentially influence estrogen-responsive gene expression and that together, 17β-estradiol, Trx, and TrxR alter hydrogen peroxide (H2O2) levels in MCF-7 cells. Our findings suggest that Trx and TrxR are multifunctional proteins that, in addition to modulating H2O2 levels and transcription factor activity, aid ER
in regulating the expression of estrogen-responsive genes in target cells.
Copyright © 2009 by the Society for Endocrinology.